Search
News
Important Only
Other
Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S Disease
March 26 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O:ACUMEN PHARMACEUTICALS COMPLETES ENROLLMENT OF ALTITUDE-AD, A PHASE 2 CLINICAL TRIAL OF SABIRNETUG (ACU193) IN EARLY ALZHEIMER’S DISEASEACUMEN PHARMACEUTICALS INC - TOPLINE RESULTS EXPECTED IN LATE 2026Reuters
Mar 26, 2025
Other
Calidi Biotherapeutics And City Of Hope Provide Update On A Phase 1 Clinical Trial With CLD-101 Virotherapy In Patients With Recurrent High-Grade Glioma
March 26 (Reuters) - Calidi Biotherapeutics Inc CLDI.A:CALIDI BIOTHERAPEUTICS AND CITY OF HOPE PROVIDE UPDATE ON A PHASE 1 CLINICAL TRIAL WITH CLD-101 VIROTHERAPY IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAReuters
Mar 26, 2025
Other
Samfine Creation Holdings Group Limited Announces Receipt Of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
March 26 (Reuters) - Samfine Creation Holdings Group Ltd SFHG.O:SAMFINE CREATION HOLDINGS GROUP LIMITED ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER REGARDING MINIMUM BID PRICE DEFICIENCYReuters
Mar 26, 2025
Other
CWTI Contracted to Design and Fabricate Fully Automated Irrigation Pumping Station to Deliver 18,000 Litres of Water Per Minute
March 26 (Reuters) - Current Water Technologies Inc WATR.V:CWTI CONTRACTED TO DESIGN AND FABRICATE FULLY AUTOMATED IRRIGATION PUMPING STATION TO DELIVER 18,000 LITRES OF WATER PER MINUTEReuters
Mar 26, 2025
Other
Supira Medical Secures $120M Oversubscribed Series E Financing And Completes Enrollment Of Support I Early Feasibility Study In The United States
March 26 (Reuters) - SUPIRA MEDICAL SECURES $120M OVERSUBSCRIBED SERIES E FINANCING AND COMPLETES ENROLLMENT OF SUPPORT I EARLY FEASIBILITY STUDY IN THE UNITED STATESSUPIRA MEDICAL: ROUND WAS LED BY NEW INVESTORS NOVO HOLDINGS AND QATAR INVESTMENT AUTHORITY (QIA)Reuters
Mar 26, 2025
Other
Trimble Receives Expected Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Annual Report On Form 10-K For Fiscal 2024
March 26 (Reuters) - Trimble Inc TRMB.O:TRIMBLE RECEIVES EXPECTED NOTIFICATION OF DEFICIENCY FROM NASDAQ RELATED TO DELAYED FILING OF ANNUAL REPORT ON FORM 10-K FOR FISCAL 2024Reuters
Mar 26, 2025
Other
New Nipocalimab Data And Real-World Research At Aan 2025 Highlight Positive Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis (gMG)
March 26 (Reuters) - Johnson & Johnson JNJ.N:NEW NIPOCALIMAB DATA AND REAL-WORLD RESEARCH AT AAN 2025 HIGHLIGHT POSITIVE PHASE 3 RESULTS AND COMMITMENT TO PEOPLE LIVING WITH GENERALIZED MYASTHENIA GRAVIS (GMG)Reuters
Mar 26, 2025
Other
Activist Starboard nominates three directors for Autodesk
March 26 (Reuters) - Starboard Value is nominating three directors to design and engineering software maker Autodesk's ADSK.O board, the activist investor said on Wednesday, rekindling its proxy battle with the company over margin concerns.Reuters
Mar 26, 2025
Other
Supira Medical Secures $120M Oversubscribed Series E Financing And Completes Enrollment Of Support I Early Feasibility Study In United States
March 26 (Reuters) - SUPIRA MEDICAL SECURES $120M OVERSUBSCRIBED SERIES E FINANCING AND COMPLETES ENROLLMENT OF SUPPORT I EARLY FEASIBILITY STUDY IN UNITED STATESReuters
Mar 26, 2025
Featured Tools
Top News
Musk’s XChat Is Coming to App Store, Meta, Apple and Finance World Are Trembling
Anthropic IPO 2026: What the Claude Mythos Release Delay Means for Investors and Stock Valuation
Microsoft Launches Its Own AI Models and Ditches OpenAI Dependence - Is MSFT Stock a Buy at $370?
Anthropic Claude Mythos Preview Sparks Wall Street Panic: Bessent, Powell Summon CEOs; Cloudflare Tumbles 8%
Intel Stock's Rare Surge: What’s Driving the Rally and Is It Worth Buying in 2026?
Market Movers
Tradingkey
